Trade name: Clexane

Pharmacology

Pharmacodynamics:

Mechanism of action
Facilitates antithrombin binding to prothrombin but not thrombin

Pharmacokinetics:

Administration: subcutaneously so patients can even do it themselves. Always adjusted to body weight. do not give iv or im
Distribution: increased bioavailability when compared with UF heparin
Metabolism:
Excretion: Half life is 4-6 hours (longer than heparin) and is eliminated in urine (so you need a patient with good renal function)

Indications:

Its really fast so used to

  • prevent DVT (prophylaxis) post op immobile patients etc
  • treat DVT - bridging therapy with warfarin
  • coronary syndromes (sometimes)
Contraindications:
Risks and ADRS:

if overcooked
haemorrhage
bruising

elevated AST ALT and hyperkalaemia

thrombocytopenia not generally considered major

Interactions:
Other notes

not as reversible with protamine sulphate as with UF hepatin
action is assessed using antifactor Xa activity